The COVID-19 public health emergency is slated to end in the U.S. on May 11. While many companies that benefited from an uptick in demand during the early stages of the pandemic saw their share prices boom and bust over the past few years, there are some that are still at far higher values than where they were before the pandemic started.

Three of the best-performing healthcare stocks since then include Moderna (NASDAQ: MRNA), McKesson (NYSE: MCK), and Eli Lilly (NYSE: LLY). Here's a look at why these three stocks have done so well since 2020 and whether they're still good buys today.

Moderna gained plenty of attention these past few years for its COVID-19 vaccine Spikevax. Prior to its development, the healthcare company was far less known. Some doubts about the continuing high-level demand for COVID-19 vaccines have been raised, but investors overall remain bullish on the company. It has multiple products in its approval pipeline, including a vaccine for the respiratory syncytial virus that has been highly effective in late-stage trials. There's also the possibility that there will be a need for annual booster shots for COVID-19.

Continue reading

Source Fool.com